🌱 ESG Policy

PlexoA GmbH – Biotech Consulting & Advisory

Effective Date: 06.05.2025
Approved by: Dr. Indrabahadur Singh, Founder & Managing Director
Next Review: 1 year from today

🔹 Introduction

At PlexoA GmbH, we are committed to advancing innovation in biotechnology responsibly and sustainably. As a bootstrapped company supporting the biotech drug discovery ecosystem, we recognize the role that environmental care, social responsibility, and sound governance play in building long-term, ethical value for our clients, partners, and the scientific community.

🌍 Environmental Responsibility

Although we are a digital-first advisory firm, we strive to minimize our environmental footprint through:

  • A remote-first operating model, reducing emissions from office space and commuting.
  • Use of energy-efficient cloud computing and sustainable tech partners in the development of PlexoBio.
  • Limiting travel by prioritizing virtual collaboration and meetings.
  • Choosing vendors and collaborators that value sustainability and green tech.

Future Commitments:

  • Conduct an internal environmental audit of digital infrastructure.
  • Offset a portion of emissions linked to cloud usage or essential travel.

🤝 Social Responsibility

We aim to contribute positively to the biotech sector and society by:

  • Promoting a culture of ethics, inclusion, and integrity within our team and partnerships.
  • Supporting fair labor practices and equal opportunity, regardless of background, gender, or geography.
  • Working with clients and partners who align with ethical biotech standards, particularly regarding human and environmental safety.
  • Sharing knowledge openly to advance global scientific progress through transparent, equitable innovation.

Future Commitments:

  • Formalize a Diversity, Equity & Inclusion (DEI) pledge.
  • Sponsor or mentor underrepresented biotech professionals as we grow.

🏛️ Governance Practices

Our governance principles reflect transparency, integrity, and long-term stewardship:

  • Operate with financial prudence and compliance with German and EU regulations.
  • Maintain clear data privacy and IP protection standards, critical in biotech and digital health.
  • Avoid conflicts of interest and disclose any advisory relationships that may affect due diligence services.
  • Apply scientific objectivity and risk awareness in all R&D assessments.

Future Commitments:

  • Establish an external Scientific & Ethics Advisory Board for PlexoBio.
  • Publish an annual ESG impact update starting 20XX.

📈 Continuous Improvement

This policy will be reviewed annually as PlexoA grows and as ESG expectations evolve. We will remain agile, transparent, and committed to learning from industry best practices.

Signed,
Dr. Indrabahadur Singh
Founder & Managing Director
PlexoA GmbH
06.05.2025